Cyvex Nutrition and Solanic have formed a global distribution alliance for the dietary and weight management supplement SolaThin. This alliance will streamline global operations, with Cyvex assuming all duties relating to the supplement’s sales, promotion, support and further development. SolaThin is a pure potato protein extract consisting of several low molecular weight proteins, including protease inhibitor PI-2. PI-2 enables the release of cholecystokinin (CKK), a naturally occurring peptide shown to produce a feeling of gastric fullness, and thereby helping reduce food consumption. Under the new alliance, SolaThin will be further studied in a human clinical trial involving 60 adult subjects, with three treatment arms expected to be completed by fourth quarter of 2011. For further information: www.cyvex.com; www.solanic.eu